Core Viewpoint - The announcement from Shichuang Energy (002779.SZ) regarding the change in indirect shareholding of its actual controller, Su Liming, due to his divorce from Wang Yanxiao, will not affect the company's control structure or governance [1][2][3]. Shareholding Structure - Su Liming, through Shichuang Investment, holds 142,941,654 shares, accounting for 35.74% of the total share capital, while Nanjing Sicheng holds 137,231,879 shares, representing 34.31% [1]. - After the shareholding change, Su Liming's indirect shareholding will decrease from 115,524,348 shares (28.88%) to 81,362,547 shares (20.34%), while Wang Yanxiao will acquire approximately 34,161,801 shares (8.54%) [2][3]. Control Rights - Despite the shareholding changes, Su Liming will still control approximately 70.04% of the voting rights through Shichuang Investment and Nanjing Sicheng, maintaining his position as the actual controller of the company [2][3]. Financial Information - The market value of the shares transferred to Wang Yanxiao is estimated at approximately 446 million yuan, based on the closing price of 13.07 yuan per share on December 30 [4]. - Shichuang Energy raised a net amount of 700.93 million yuan from its IPO, which was lower than the planned amount by 395.04 million yuan [4][5]. Company Background - Shichuang Energy, established in 2009 and located in Changzhou, Jiangsu Province, primarily engages in manufacturing [5].

Core Viewpoint - Zhongjian Technology (002779.SZ) announced the expiration of its 2023 plan for issuing shares to specific targets, with the decision valid for 12 months from December 28, 2023, to December 27, 2024 [1] Group 1 - The company held multiple meetings in December 2023 to approve the issuance plan and authorized the board to handle related matters [1] - The total amount to be raised from the issuance is not exceeding 785.19 million yuan, which will be used for various projects including the construction of a riding lawn mower production line and a new energy intelligent garden machinery project [3][4] - The company has not yet determined specific issuance targets, making it unclear if the issuance will constitute a related party transaction [4] Group 2 - The decision regarding the issuance has expired, rendering the plan automatically invalid [3] - If the maximum number of shares (39.6 million) is issued, the controlling shareholders' stake will decrease to 31.35%, but they will remain the actual controllers of the company [5] - The company is also preparing for an overseas issuance of H-shares to enhance its international strategy and financing capabilities, with the board authorizing management to initiate preparations [5][6]

Group 1 - The conference focused on "New Technologies, New Services, New Models to Promote International Cooperation" and aimed to gather representatives from government, industry, academia, and international organizations to discuss new paths for international cooperation in headquarters economy [1][2] - Over 200 representatives from various sectors, including government departments, research institutions, financial institutions, and international organizations, participated in discussions to enhance the international influence of headquarters enterprises and build a collaborative development ecosystem [2][3] - The President of the Beijing Headquarters Enterprise Association emphasized the need for headquarters enterprises to leverage digital technology and industry integration trends to enhance international competitiveness and value chain influence [2][3] Group 2 - Multiple strategic cooperation agreements were signed during the conference, including partnerships with the China-ASEAN Legal Affairs Center and Beijing Bank to support enterprises in expanding into the ASEAN market and providing customized cross-border financing services [5] - The "Headquarters Enterprises International Production-Education-Research Service Base" was inaugurated, aiming to cultivate talents with international vision and innovative capabilities through deep integration of industry, academia, and research [5] - A policy interpretation session was held to address enterprise concerns, with officials explaining policies related to foreign direct investment, communication services, and international development support [5] Group 3 - The conference launched several initiatives, including the "Headquarters Enterprises Influence Dissemination and International Cooperation Promotion Action Plan" and the "Lancang-Mekong Silk Road Outbound Service Center" [6] - A roundtable dialogue featured discussions on new technology empowerment, service upgrades, and model innovation, providing diverse practical references for participating enterprises [9] - The event established an open and efficient international cooperation dialogue platform, aiming to deepen cross-field and cross-regional cooperation and contribute to international economic cooperation and sustainable development [10]

Group 1 - The core viewpoint of the article highlights the administrative penalties imposed on Everbright Bank's Longyan branch due to inadequate pre-loan investigations and post-loan management for personal business loans, as well as insufficient verification of the source of down payments for personal housing loans [1][3] - The Longyan Financial Supervision Bureau has fined Everbright Bank's Longyan branch a total of 1.15 million yuan for these violations [1][3] - Additionally, a warning was issued to an individual named Wang Chengjing, who is associated with the violations [1][3]

金融，是实体经济的源头活水。如何让这活水，既能润泽阡陌纵横的产业良田，又能精准滴灌每一 株亟待成长的幼苗？解题之道，正是构建一张从打通发展"大动脉"、强壮产业"主骨架"到畅通链条"微循 环"的立体服务网络，让金融活水精准抵达、澎湃奔流。 疏脉：打通枢纽"梗阻"，让区域经济血脉畅通 在沂蒙老区，由临沂恒新能源集团有限公司规划建设的铁路支线与现代化储煤棚，曾是连接供暖民 生与物流降本的关键"最后一公里"，却因巨大的前期投入而陷入"等米下锅"的困境。资金，成了横亘在 理想蓝图与现实工地之间最深的沟壑。恒丰银行临沂分行在一次走访中敏锐捕捉到这一痛点，迅速启动 总分支三级联动响应机制。这不是一次普通的贷款审批，而是一场与民生保障和区域发展赛跑的"火线 支援"。从深入调研到方案定制，再到8.6亿元"公铁物流贷"的迅速批复，恒丰银行以高效率的"集团军作 战"，将金融"弹药"精准投送到项目前线。如今，铁路线蜿蜒伸展，储煤棚巍然矗立，它不仅温暖了9万 余户家庭的冬日，更将成为激活临沂南部物流经济的强大心脏。 壮骨：信用"点石成金"，为硬核产业注入强心剂 产业链的韧性，往往取决于最末梢小微细胞的活力。在潍坊，一家铝模板制造企业因 ...

Core Insights - The Beijing Municipal Health Commission has issued the "Action Plan for Supporting the Development of Artificial Intelligence Applications in the Medical and Health Field (2026-2027)" and "Several Measures to Support the Innovative Development of the Artificial Intelligence Industry in the Medical and Health Field (2026-2027)" [1] Group 1: Action Plan Overview - The Action Plan focuses on three dimensions: core application scenarios, expanding application scenarios, and increasing support and guarantee efforts, deploying 16 key tasks [2] - Key tasks include promoting clinical diagnosis assistance, grassroots health, and health management, encouraging collaboration between medical institutions and quality AI companies, and constructing a new paradigm for drug and device research and development driven by AI technology [2][3] Group 2: Measures for AI Development - The Measures outline four dimensions: focusing on clinical demand scenarios, strengthening data governance, optimizing support systems, and enhancing policy guarantees, deploying 15 key tasks [4] - The goal is to create a full-process research and application model for medical AI products, aiming for breakthroughs in cutting-edge AI technologies in healthcare and mutual empowerment of the industry by 2027 [4]

2025年12月30日，北京未来医药产业链研究院成立仪式在北京市昌平区举行。 工业和信息化部消费品工业司、北京市经济和信息化局和昌平区委、区政府相关领导，医药领域全国性 行业协会和部分研究机构、骨干企业代表等共100余人齐聚现场，共同见证研究院揭牌启航。 北京未来医药产业链研究院是在工业和信息化部消费品工业司指导推动下，由医药领域多家全国性行业 协会、研究机构、重点企业联合发起成立的标杆性医药产业链服务平台。研究院聚焦四大职能定位：打 造全球领先的医药产业战略智库，着力开展行业运行分析和前瞻性战略研判；打造行业认可的医药科技 成果转化平台，推动加快医药科技创新成果产业化；打造高效联动的医药全产业链协作促进平台，促进 产业链大中小企业合作对接和产业链各环节高效协同；打造国际一流的医药产业国际合作平台，为我国 医药产业链深度融入全球体系和全球医药产业合作提供有力支撑。 工业和信息化部消费品工业司主要负责同志在致辞中指出，组建北京未来医药产业链研究院是落实医药 工业产业链高质量发展行动的重要举措，对推进医药工业产业链高质量发展、打造生物医药新兴支柱产 业具有深远意义。研究院作为促进各方深化合作、强链聚能重要的载体， ...

Core Viewpoint - The National Medical Products Administration (NMPA) of China has released the "Priority Approval Catalog for High-end Medical Devices (2025 Edition)", which includes eight advanced medical devices for expedited approval, aiming to accelerate the market entry of innovative high-end medical equipment [1]. Group 1: Priority Approval Catalog - The catalog includes advanced medical devices such as the boron neutron capture therapy system, ultra-high field magnetic resonance imaging equipment, medical electron accelerators, and implantable brain-machine interface devices [1][2]. - The NMPA will implement priority approval for the medical devices listed in the catalog according to Article 73, Item 3 of the "Regulations on the Registration and Filing of Medical Devices" [1][5]. Group 2: Device Specifications - The boron neutron capture therapy system is designed to treat malignant tumors that are recurrent or for which there are no other conventional treatment options, utilizing a reaction between neutrons and boron to produce secondary particles that kill cancer cells [2]. - The ultra-high field magnetic resonance imaging equipment has a magnetic field strength greater than 5 Tesla [2]. - The medical electron accelerator integrates magnetic resonance imaging guidance and is used for various therapeutic applications [2]. - The implantable brain-machine interface device captures neural signals from the central nervous system through implanted electrodes, enabling interaction with external control devices for compensating motor and sensory dysfunctions [2]. - The endoscopic surgical control system employs robotic technology for operating surgical instruments through natural orifices [2]. - The transcatheter tricuspid valve repair system is suitable for high-risk patients with severe tricuspid regurgitation who are deemed unsuitable for surgical intervention [2]. - The minimally invasive glaucoma surgery (MIGS) implant establishes a drainage pathway for aqueous humor in the eye [2].

| 序号 | 板块 | 涨跌幅(%)▼ | 总成交量(万手) = 总成交额(亿元) ▼ | | 净流入 (亿元) ▼ | 上涨家数 | 下跌家数 | | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 文化传媒 | 2.75 | 3016.13 | 347.75 | 65.98 | 76 | 8 | | 2 | 教育 | 1.72 | 574.99 | 35.02 | 1.82 | 12 | ഗ | | 3 | 军工电子 | 1.33 | 1688.54 | 434.15 | 3.59 | 46 | 15 | | 4 | IT服务 | 1.30 | 2145.81 | 315.05 | 12.39 | વેર | 33 | | 5 | 通信服务 | 1.30 | 640.45 | 102.64 | 10.68 | 36 | ಡ | | 6 | 软件开发 | 1.21 | 1492.12 | 342.89 | 24.55 | 109 | 29 | | 7 | 互联网电商 | 1.00 | 166.51 | 20.58 | 1.01 | 11 | 6 | ...

Core Viewpoint - The 2026 China Exhibition Economy International Cooperation Forum (CEFCO Forum) will be held from January 21 to 23, 2026, in Wuhan, Hubei Province, focusing on high-quality development in the exhibition industry [1][2]. Group 1: Event Details - The theme of the 2026 forum is "Transformative Era: Co-creating Links, Innovating the Future" [1]. - The forum is co-hosted by the China Council for the Promotion of International Trade and four international exhibition organizations [1]. - Over 20 countries and regions have confirmed participation from exhibition institutions, enterprises, and experts [1]. Group 2: Agenda and Topics - The opening ceremony and the first plenary session will take place on the morning of January 22, 2026, followed by the second plenary session on January 23 [1]. - Key topics include the integration of exhibitions with industries, new paradigms for international exhibitions, evaluation factors for quality exhibitions, cooperation in the Greater Bay Area, digital transformation in the exhibition industry, and ESG practices [1]. - Six breakout sessions will be held to discuss these topics in detail [1]. Group 3: Reports and Agreements - During the forum, the China Council for the Promotion of International Trade will release the "China Exhibition Economy Development Report 2025" [2]. - A series of exhibition cooperation project signing ceremonies will also take place [2].